Status:
RECRUITING
Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Magdi Yacoub Heart Foundation
Conditions:
Atrial Fibrillation and Flutter
Mechanical Mitral Valve Prosthesis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Oral anticoagulation (OAC) is indicated in a wide variety of clinical conditions including atrial fibrillation (AF), mechanical valve prosthesis (MVP), deep vein thrombosis and pulmonary embolism. Alt...
Detailed Description
Study Methods * Population of study: Patients who have a clinical indication for long term VKA. * Study location: Aswan Heart Center. * Inclusion criteria: Adult patients above 18 years who are indic...
Eligibility Criteria
Inclusion
- Adult patients above 18 years who are indicated for long term VKA and has been on VKA for more than 6 months.
Exclusion
- Refusal to join the study.
- History of prior life-threatening bleeding or thrombo-embolic events.
- Illiterate patients with no caregivers living at the same home.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
586 Patients enrolled
Trial Details
Trial ID
NCT06187155
Start Date
December 1 2023
End Date
December 1 2024
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan Heart Centre
Aswān, Egypt